{"id":"placebo-for-bezafibrate","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL3739769","moleculeType":"Small molecule","molecularWeight":"345.83"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance administered in blinded clinical trials to establish baseline efficacy and safety profiles of the active comparator drug (in this case, Bezafibrate). It allows researchers to distinguish true drug effects from natural disease progression and psychological expectation effects. In this Phase 3 trial context, placebo serves as the control arm against which Bezafibrate's efficacy and tolerability are measured.","oneSentence":"Placebo produces no pharmacological effect and serves as a control comparator in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:58.092Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 trial of Bezafibrate (fibrate for dyslipidemia/cardiovascular risk reduction)"}]},"trialDetails":[{"nctId":"NCT04594694","phase":"PHASE2","title":"Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC","status":"TERMINATED","sponsor":"Intercept Pharmaceuticals","startDate":"2019-10-02","conditions":"Primary Biliary Cholangitis","enrollment":75},{"nctId":"NCT05239468","phase":"PHASE2","title":"Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC","status":"COMPLETED","sponsor":"Intercept Pharmaceuticals","startDate":"2022-03-21","conditions":"Primary Biliary Cholangitis","enrollment":72},{"nctId":"NCT01654731","phase":"PHASE3","title":"Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-10-15","conditions":"PBC","enrollment":100},{"nctId":"NCT04751188","phase":"PHASE3","title":"A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis","status":"UNKNOWN","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2020-10-02","conditions":"Primary Biliary Cirrhosis","enrollment":11},{"nctId":"NCT02584504","phase":"PHASE3","title":"Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2015-11-30","conditions":"Hypercholesterolemia","enrollment":163},{"nctId":"NCT02937012","phase":"PHASE3","title":"Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders","status":"UNKNOWN","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2016-10","conditions":"Primary Biliary Cirrhosis","enrollment":34}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":149,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Does not apply"],"phase":"phase_3","status":"active","brandName":"Placebo (for Bezafibrate)","genericName":"Placebo (for Bezafibrate)","companyName":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","companyId":"instituto-nacional-de-ciencias-medicas-y-nutricion-salvador-zubiran","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo produces no pharmacological effect and serves as a control comparator in clinical trials. Used for Control arm in Phase 3 trial of Bezafibrate (fibrate for dyslipidemia/cardiovascular risk reduction).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}